USD10
AZN acciones
Acerca de AstraZenecaA merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
USD10
AZN acciones
Acerca de AstraZenecaA merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
Estadísticas
VENTANA DE OPERACIÓN
Cerrado
ABRE A LAS
26 mar at 13:30 GMT+0
CAPITALIZACIÓN DE MERCADO
290,22 mil M US$
PRECIO DE APERTURA
No hay suficientes datos
BAJO (1Y)
122,26 US$
ALTO (1Y)
212,71 US$
BAJO (24H)
186,33 US$
Alza (24H)
188,72 US$